Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:158:104891.
doi: 10.1016/j.phrs.2020.104891. Epub 2020 May 7.

Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

Maciej Banach  1 , Peter E Penson  2 , Zlatko Fras  3 , Michal Vrablik  4 , Daniel Pella  5 , Željko Reiner  6 , Seyed Mohammad Nabavi  7 , Amirhossein Sahebkar  8 , Meral Kayikcioglu  9 , Magdalena Daccord  10 ; FH Europe and the International Lipid Expert Panel (ILEP)
Affiliations

Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

Maciej Banach et al. Pharmacol Res. 2020 Aug.

Abstract

Individuals with Familial Hypercholesterolaemia (FH) are at very high risk of cardiovascular disease, which is associated with poor outcomes from coronavirus infections. COVID-19 puts strain on healthcare systems and may impair access to routine FH services. On behalf of the International Lipid Expert Panel (ILEP) and the European FH Patient Network (FH Europe), we present brief recommendations on the management of adult patients with FH during the COVID-19 pandemic. We discuss the implications of COVID-19 infections for FH patients, the importance of continuing lipid-lowering therapy where possible, issues relating to safety monitoring and service delivery. We summarise the evidence for additional benefits of statins and other lipid-lowering drugs during viral infections. The recommendations do not override in any way the individual responsibility of physicians to make appropriate and accurate decisions taking into account the condition of a given patient and the doses, rules, and regulations applicable to drugs and devices at the time of their prescription/use.

Keywords: Cholesterol; Coronavirus; Covid-19; Prevention; Risk stratification; Statins; Therapy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest No professional writer was involved in the preparation of this review.

References

    1. EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz A.J., De Marco M., Stevens C.A.T., Akram A., Freiberger T., Hovingh G.K., Kastelein J.J.P., Mata P., Raal F.J., Santos R.D., Soran H., Watts G.F., Abifadel M., Aguilar-Salinas C.A., Al-Khnifsawi M., AlKindi F.A., Alnouri F., Alonso R., Al-Rasadi K., Al-Sarraf A., Ashavaid T.F., Binder C.J., Bogsrud M.P., Bourbon M., Bruckert E., Chlebus K., Corral P., Descamps O., Durst R., Ezhov M., Fras Z., Genest J., Groselj U., Harada-Shiba M., Kayikcioglu M., Lalic K., Lam C.S.P., Latkovskis G., Laufs U., Liberopoulos E., Lin J., Maher V., Majano N., Marais A.D., März W., Mirrakhimov E., Miserez A.R., Mitchenko O., Nawawi H.M., Nordestgaard B.G., Paragh G., Petrulioniene Z., Pojskic B., Postadzhiyan A., Reda A., Reiner Ž., Sadoh W.E., Sahebkar A., Shehab A., Shek A.B., Stoll M., Su T.C., Subramaniam T., Susekov A.V., Symeonides P., Tilney M., Tomlinson B., Truong T.H., Tselepis A.D., Tybjærg-Hansen A., Vázquez-Cárdenas A., Viigimaa M., Vohnout B., Widén E., Yamashita S., Banach M., Gaita D., Jiang L., Nilsson L., Santos L.E., Schunkert H., Tokgözoğlu L., Car J., Catapano A.L., Ray K.K., EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Atherosclerosis. 2018;277:234–255. - PubMed
    1. https://www.worldometers.info/coronavirus/. (Last accessed: 1st May 2020).
    1. https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/. (Last accessed: 1st May 2020).
    1. U.S. Centers for Disease Control and Prevention; 2020. Coronavirus Disease 2019 (COVID-2019)https://www.cdc.gov/coronavirus/2019-ncov/index.html (Last accessed 30 March 2020)
    1. Vallejo-Vaz A.J., Kondapally Seshasai S.R., Cole D., Hovingh G.K., Kastelein J.J., Mata P., Raal F.J., Santos R.D., Soran H., Watts G.F., Abifadel M., Aguilar-Salinas C.A., Akram A., Alnouri F., Alonso R., Al-Rasadi K., Banach M., Bogsrud M.P., Bourbon M., Bruckert E., Car J., Corral P., Descamps O., Dieplinger H., Durst R., Freiberger T., Gaspar I.M., Genest J., Harada-Shiba M., Jiang L., Kayikcioglu M., Lam C.S., Latkovskis G., Laufs U., Liberopoulos E., Nilsson L., Nordestgaard B.G., O’Donoghue J.M., Sahebkar A., Schunkert H., Shehab A., Stoll M., Su T.C., Susekov A., Widén E., Catapano A.L., Ray K.K. Familial hypercholesterolaemia: a global call to arms. Atherosclerosis. 2015;243(1):257–259. - PubMed

Substances